Antibiotics in Bangladesh: A Crisis Unfolding

Document Type : Editorial
Abstract

Antibiotics once stood as one of humanity’s greatest medical triumphs reliable weapons against bacterial infections that claimed millions of lives. In Bangladesh, as in many parts of the world, antibiotics have long been essential, saving lives when infections spread in overcrowded settings, or where sanitation is uneven. Yet over the last decades, a troubling pattern has emerged: antibiotics are being used too often, too casually, and often inappropriately. And the result is a rising tide of resistance that threatens to make ordinary infections untreatable.

Recent data paint a sobering picture. According to the 2025 report by Institute of Epidemiology, Disease Control and Research (IEDCR), a large share of patients admitted in intensive care units (ICUs) in Bangladesh no longer respond to common antibiotics roughly 4 in 10 ICU patients are not responding to available drugs[1]. A 2025 media report noted that some critical antibiotics now show 79–97% resistance in Bangladesh[2].Meanwhile, colonization studies show that even healthy individuals in communities are harboring drug-resistant bacteria: in one urban study, a high prevalence of extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE), carbapenem-resistant Enterobacterales (CRE), and methicillin-resistant Staphylococcus aureus (MRSA) was found among both hospital and community participants[3].Many of the first-line antibiotics once reliable for pneumonia, urinary tract infections, or wound infections are rapidly losing their potency. For people in Bangladesh, this means that a simple infection could escalate into a life-threatening condition. For the health system, it means longer hospital stays, more expensive second-line treatments, and higher risks of complications, disability, or death. As one recent report warns, the danger of antibiotic resistance must not be ignored anymore[4].

Root Causes in Bangladesh

Understanding the current crisis in Bangladesh demands confronting a complex mix of social, economic, regulatory, and cultural factors. Several intersecting dynamics fuel overuse, misuse, and ultimately resistance.

Ease of Access & Self-medication

One of the most immediate problems is that antibiotics are often available over the counter and used without proper prescription. A 2023 review of rural Bangladesh found that the availability of antibiotics without prescriptions remains a significant driver of antimicrobial resistance (AMR)[5]. Among university students in urban areas, self-medication is widespread. In one 2022–2023 study at three Bangladeshi universities, 61% of respondents reported self-medicating with antibiotics in the prior six months[6]. Many did so for common ailments like fever, cough or cold despite the fact that such illnesses are often viral and do not require antibiotics.

Less awareness about when antibiotics are necessary is another problem: in a cross-sectional survey, many people lacked knowledge about the proper use of antibiotics or the concept of resistance[7].

2. Poor Healthcare Infrastructure and Informal Providers

In rural and peri-urban areas, many patients do not have access to qualified doctors. Instead, they relyon informal providers village doctors,unqualified practitioners, or pharmacy shopkeepers for healthcare and advice[8].

In some studies, the number of unqualified village practitioners outnumber qualified (MBBS‑level) physicians in rural clusters. This gap in formal medical care pushes people toward self-medication and over-the-counter antibiotic purchase.

3. Over-prescribing and Inappropriate Prescriptions

Even when patients do see a qualified physician, over-prescribing remains common. The combination of poor diagnostics (lack of lab support), doctors’ tendency to prescribe “just in case,” and patient pressure to get quick results often encourages the useof broad-spectrum antibiotics.

During the COVID-19 pandemic, the problem worsened: fear of secondary infections, uncertainty about symptoms, and limited diagnostics led to increased antibiotic misuse even when infections were viral.

4. Use in Agriculture, Livestock, and Aquaculture

Another important driver often overlooked is the use of antibiotics outside human medicine particularly in livestock, poultry, and aquaculture. In many farms, antibiotics are used not only for treatment but also prophylactically, and sometimes as growth promoters.

These practices introduce resistant bacteria into the food chain through meat, fish or other animal products or agricultural environment. Over time, these bacteria may colonize farm workers, consumers, or spread into the wider community. The 2023 colonization study in Bangladesh indeed found high levels of resistant bacteria in both hospitals and community settings.

5. Weak Regulatory Implementation & Lack of Surveillance

Although the government has recognized the problem for example through a national AMR surveillance program under the National Antimicrobial Resistance Surveillance (2016–2023) led by IEDCR implementation remains weak.

In many places, laws that prohibit over-the-counter antibiotic sales are rarely enforced due to lack of manpower, insufficient inspection capacity, and weak follow-up.

Moreover, surveillance data remain patchy: while there have been important studies, large-scale systematic monitoring across rural and urban areas, hospitals and community settings is still limited.

More thanNumbers, Human Lives at Risk

The rise of antibiotic resistance in Bangladesh is not merely a technical issue it carries very real human consequences.

When first-line antibiotics fail, patients endure longer sickness, more severe symptoms, and often require second-line or third-line drugs, which may be costlier or less available.

According to a global burden study, in 2019, Bangladesh had approximately 26,200 deaths attributable to AMR, and 98,800 deaths associated with AMR[9]. These numbers underline that AMR is already contributing substantially to mortality.

Resistant infections often require longer hospitalization, more expensive drugs, and diagnostic tests costs that many low-income families in Bangladesh cannot afford. This exacerbates social inequality: poor patients may delay or avoid treatment, risking worse health outcomes.

Common surgeries, childbirth, newborn care all rely on effective antibiotics to prevent or treat infection. Growing resistance threatens these basic medical services, undermining decades of progress in healthcare.

Resistant bacteria don’t stay confined to hospitals. Once they emerge whether through community misuse or agricultural use they can spread widely, colonizing healthy people, contaminating water sources, and entering the environment. The 2023 colonization study showed high rates of resistant bacteria in community individuals, underscoring this risk.

Recommendations and Prevention

Confronting antibiotic resistance in Bangladesh will require a coordinated, multifaceted effort from government regulation and health-system reform, to community education and behavioral change. Below are key recommendations.

Ensure that regulations prohibiting over‑the‑counter antibiotic sales are enforced rigorously. Pharmacy shops, model pharmacies or community pharmacies should sell antibiotics only against valid prescriptions issued by qualified physicians. Expand capacity of regulatory bodies (e.g., by training inspectors, funding regular audits, using mobile units) so that enforcement becomes feasible even outside major urban centers. Strengthen national AMR surveillance under agencies such as IEDCR: invest in laboratory capacity, data collection, and reporting so that patterns of resistance are monitored in real time across hospitals,communities, and rural areas.

Involve and empower pharmacists, clinicians, and hospital staff in AMS programs: they should counsel patients on the correct use of antibiotics, the importance of completing full courses, and the dangers of misuse. Invest in diagnostics especially rapid, affordable diagnostics so that physicians can distinguish between bacterial and viral infections, and prescribe antibiotics only when necessary.

Develop and disseminate national treatment guidelines aligned with global standards (e.g., using the World Health Organization AWaRe classification) so that first‑line, “Access” antibiotics are used appropriately, and “Watch” or “Reserve” antibiotics are reserved for serious or resistant cases. Mobilize government funding, donorsupport, and public–private partnerships to build laboratory capacity, public health infrastructure, and AMR surveillance networks.Work with global initiatives and organizations to align Bangladesh’s AMR efforts with international standards, and benefit from best practices, technical support, and resources. Promote “One Health” approach recognizing that human health, animal health, and environment are interconnected to address antibiotic resistance holistically.

Antibiotics once offered hope a way to treat infections, save lives, and build healthier communities. In Bangladesh, they have become ubiquitous, often misused, and increasingly ineffective. The rapid rise of antibiotic resistance is not just a medicalcrisis, but a social one: it threatens the health of individuals, the stability of families, the viability of the healthcare system, and the future of public health.

The fact that Bangladesh has established a national AMR surveillance program, that government agencies and international bodies acknowledge the problem, that researchers continue to document the crisis all of this means we still have time to change course. The growing public awareness, the willingness of some policymakers to tighten regulation (e.g., under the Drug and Cosmetic Act), andthe growing body of local research are signs that Bangladesh can and must rise to the challenge.

Declarations:

Ethical approval

Ethics approval was not required for this editorial.

Consent

Informed consent was not required for this editorial.

Sources offunding

No funding was acquired for this paper.

Author’s contribution

All author contributed to finalize this manuscript

Conflicts of interest disclosure

The authors declare that there is no conflict of interest.

Data availability statement

It will beavailable on reasonable request.

References:

1.https://www.thedailystar.net/health/news/four-10-icu-patients-not-responding-antibiotics-iedcr-4042696

2.https://www.thedailystar.net/health/disease/who/news/some-critical-antibiotics-now-show-79-97-resistance-4010276

3.Chowdhury, F., Mah-E-Muneer, S., Bollinger, S., Sharma, A., Ahmed, D., Hossain, K., Hassan, M. Z., Rahman, M., Vanderende, D., Sen, D., Mozumder, P., Khan, A. A., Sarker, M., Smith, R. M., Styczynski, A., & Luvsansharav, U. O. (2023). Prevalence of Colonization With Antibiotic-Resistant Organisms in Hospitalized and Community Individuals in Bangladesh, a Phenotypic Analysis: Findings From the Antibiotic Resistance in Communities and Hospitals (ARCH) Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,77(Suppl 1), S118–S12

4. https://doi.org/10.1093/cid/ciad2544.https://www.thedailystar.net/opinion/editorial/news/the-danger-antibiotic-resistance-must-not-be-ignored-anymore-4043246

5.Bepari AK, Rabbi G, Shaon HR, Khan SI, Zahid ZI, Dalal K, Reza HM. Factors Driving Antimicrobial Resistance in Rural Bangladesh: A Cross-Sectional Study on Antibiotic Use-Related Knowledge, Attitude, and Practice Among Unqualified Village Medical Practitioners and PharmacyShopkeepers. Adv Ther. 2023 Aug;40(8):3478-3494. doi: 10.1007/s12325-023-02547-5. Epub 2023 Jun 8. PMID: 37291375; PMCID: PMC10329962.

6.Wahab A, Alam MM, Hasan S, Halder S, Ullah MO, Hossain A. Exploring the
Page 4Page 4Editorialknowledge, practices & determinants of antibiotic self-medication among bangladeshi university students in the era of COVID-19: A cross-sectional study. Heliyon. 2023 Sep 1;9(9).

7.Hossain MJ, Jabin N, Ahmmed F, Sultana A, Abdur Rahman SM, Islam MR. Irrational use of antibiotics and factors associated with antibiotic resistance: findings from a cross‐sectional study in Bangladesh. Health science reports. 2023 Aug;6(8):e1465.

8.Bepari AK, Rabbi G, Shaon HR, Khan SI, Zahid ZI, Dalal K, Reza HM. Factors driving antimicrobial resistance in rural Bangladesh: A cross-sectional study on antibiotic use-related knowledge, attitude, and practice among unqualified village medical practitioners and pharmacy shopkeepers. Advances in Therapy. 2023 Aug;40(8):3478-94.

9.https://www.healthdata.org/sites/default/files/2023-09/Bangladesh.pdf

Main Subjects :

Antibiotics in Bangladesh: A Crisis Unfolding

History
Receive Date : December 1, 2025
Accept Date : December 17, 2025
Publish Date : December 20, 2025
Antibiotics in Bangladesh: A Crisis Unfolding. (2025). Voice of Doctors Journal, 3(1), 4-6.
Statistics
Article View : 118